PTCT


PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined

PTC Therapeutics (PTCT) has announced that the US Food and Drug Administration (FDA) has approved Evrysdi (risdiplam), the first at-home, orally administered treatment …

Sectoral’s Jerome Pfund Is Losing Faith in PTC Therapeutics, Inc. (PTCT), Starting to Pull Away from Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and DexCom, Inc. (DXCM)

Here’s a glimpse into this hedge fund guru’s Q2 moves that reeled back in three biotech players.

Analysts Debate PTC Therapeutics, Inc. (PTCT) and DexCom, Inc. (DXCM) Worth Following Recent Binary Events

PTCT rises back amid hope for approval in nmDMD; DXCM suffers from new competition in diabetes market.

PTC Therapeutics, Inc. (PTCT): Shares Fall After Trial Fail

PTC Therapeutics, Inc. (NASDAQ:PTCT) shares tumbled nearly 16% this morning after investors learned that the company’s Ataluren Confirmatory Trial (ACT CF) in nonsense mutation cystic …

These Analysts Remain Sidelined on Two Soaring Stocks: PTC Therapeutics, Inc. (PTCT), NVIDIA Corporation (NVDA)

Both PTC Therapeutics, Inc. (NASDAQ:PTCT) and NVIDIA Corporation (NASDAQ:NVDA) stocks are on the rise today following CHMP’s recommendation and positive earnings release, respectively.

Company Update (NASDAQ:PTCT): Here’s Why PTC Therapeutics, Inc. Share Are Rising 80% Today

It’s a good day to be an investor in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT), after the the Committee for Medicinal Products for …

Analysts Weigh in on Two Volatile Healthcare Stocks: ContraVir Pharmaceuticals Inc (CTRV), PTC Therapeutics, Inc. (PTCT)

Healthcare analysts are weighing in on ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) and PTC Therapeutics, Inc. (NASDAQ:PTCT), as the stocks turned extremely volatile today.

Company Update (NASDAQ:PTCT): Here’s Why PTC Therapeutics, Inc. Shares Are Tumbling 30% Today

PTC Therapeutics, Inc. (NASDAQ:PTCT) investors are having a rough morning after the drug maker announced that the FDA has denies the company’s appeal of the Refuse …

Analysts Remain Positive On GenMark Diagnostics, Inc (GNMK) And PTC Therapeutics, Inc. (PTCT) As Shares Hit Their Lowest Levels

Analysts are weighing in on medical test maker GenMark Diagnostics, Inc (NASDAQ:GNMK) and biotech firm PTC Therapeutics, Inc. (NASDAQ:PTCT), as both stocks hit their 52-week …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts